Chitinase inhibition promotes atherosclerosis in hyperlipidemic mice

American Journal of Pathology

Volumn 183, Issue 1, 2013, Pages 313-325

  Kitamoto, Shiro ^a,b   Egashira, Kensuke ^b   Ichiki, Toshihiro ^b   Han, Xinbing ^a   McCurdy, Sara ^c   Sakuda, Shohei ^d   Sunagawa, Kenji ^b   Boisvert, William A ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF HAWAII   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; ALLOSAMIDIN; APOLIPOPROTEIN A1; ARGINASE 1; CD36 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHITINASE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; PROTEIN FIZZ1; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR AI; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL LINE; CELL POLARITY; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENZYME INHIBITION; EXPERIMENTAL MONKEY; GENETIC TRANSFECTION; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACETYLGLUCOSAMINE; ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CELL LINE; CHITINASE; CYTOKINES; ENZYME INHIBITORS; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRISACCHARIDES;

EID: 84879397603     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.04.003     Document Type: Article

References (48)

1. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
2. P.R. Moreno, E. Falk, I.F. Palacios, J.B. Newell, V. Fuster, and J.T. Fallon Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture Circulation 90 1994 775 778
3. G.H. Renkema, R.G. Boot, F.L. Au, W.E. Donker-Koopman, A. Strijland, A.O. Muijsers, M. Hrebicek, and J.M. Aerts Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages Eur J Biochem 251 1998 504 509
4. R.G. Boot, T.A. van Achterberg, B.E. van Aken, G.H. Renkema, M.J. Jacobs, J.M. Aerts, and C.J. de Vries Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages Arterioscler Thromb Vasc Biol 19 1999 687 694
5. M. Artieda, A. Cenarro, A. Gañán, I. Jericó, C. Gonzalvo, J.M. Casado, I. Vitoria, J. Puzo, M. Pocoví, and F. Civeira Serum chitotriosidase activity is increased in subjects with atherosclerosis disease Arterioscler Thromb Vasc Biol 23 2003 1645 1652
6. S. Sakuda, A. Isogai, S. Matsumoto, and A. Suzuki Search for microbial insect growth regulators. II Allosamidin, a novel insect chitinase inhibitor J Antibiot (Tokyo) 40 1987 296 300
7. N.K. Schiller, A.S. Black, G.P. Bradshaw, D.J. Bonnet, and L.K. Curtiss Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice J Lipid Res 45 2004 1398 1409
8. M.J. Kuranda, and P.W. Robbins Chitinase is required for cell separation during growth of Saccharomyces cerevisiae J Biol Chem 266 1991 19758 19767
9. R. Ricci, G. Sumara, I. Sumara, I. Rozenberg, M. Kurrer, A. Akhmedov, M. Hersberger, U. Eriksson, F.R. Eberli, B. Becher, J. Boren, M. Chen, M.I. Cybulsky, K.J. Moore, M.W. Freeman, E.F. Wagner, C.M. Matter, and T.F. Luscher Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis Science 306 2004 1558 1561
10. Y. Matsushima, T. Sakurai, A. Ohoka, T. Ohnuki, N. Tada, Y. Asoh, and M. Tachibana Four strains of spontaneously hyperlipidemic (SHL) mice: phenotypic distinctions determined by genetic backgrounds J Atheroscler Thromb 8 2001 71 79
11. L.J. Pinderski, M.P. Fischbein, G. Subbanagounder, M.C. Fishbein, N. Kubo, H. Cheroutre, L.K. Curtiss, J.A. Berliner, and W.A. Boisvert Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes Circ Res 90 2002 1064 1071
12. S. Kitamoto, K. Nakano, Y. Hirouchi, Y. Kohjimoto, S. Kitajima, M. Usui, S. Inoue, and K. Egashira Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates Arterioscler Thromb Vasc Biol 24 2004 1522 1528
13. M. Di Rosa, M. Musumeci, A. Scuto, S. Musumeci, and L. Malaguarnera Effect of interferon-gamma, interleukin-10, lipopolysaccharide and tumor necrosis factor-alpha on chitotriosidase synthesis in human macrophages Clin Chem Lab Med 43 2005 499 502
14. Z. Zhu, T. Zheng, R.J. Homer, Y.-K. Kim, N.Y. Chen, L. Cohn, Q. Hamid, and J.A. Elias Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation Science 304 2004 1678 1682
15. B. Karadag, M. Kucur, F.K. Isman, M. Hacibekiroglu, and V.A. Vural Serum chitotriosidase activity in patients with coronary artery disease Circ J 72 2008 71 75
16. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
17. M. Artieda, A. Cenarro, A. Ganan, A. Lukic, E. Moreno, J. Puzo, M. Pocovi, and F. Civeira Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-reactive protein Cardiology 108 2007 297 306
18. S. Sotgiu, R. Barone, B. Zanda, G. Arru, M.L. Fois, A. Arru, G. Rosati, B. Marchetti, and S. Musumeci Chitotriosidase in patients with acute ischemic stroke Eur Neurol 54 2005 149 153
19. C.E. Hollak, S. van Weely, M.H. van Oers, and J.M. Aerts Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease J Clin Invest 93 1994 1288 1292
20. J. Brinkman, F.A. Wijburg, C.E. Hollak, J.E. Groener, M. Verhoek, S. Scheij, J. Aten, R.G. Boot, and J.M. Aerts Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease J Inherit Metab Dis 28 2005 13 20
21. H. Michelakakis, E. Dimitriou, and I. Labadaridis The expanding spectrum of disorders with elevated plasma chitotriosidase activity: an update J Inherit Metab Dis 27 2004 705 706
22. Y. Guo, W. He, A.M. Boer, R.A. Wevers, A.M. de Bruijn, J.E. Groener, C.E. Hollak, J.M. Aerts, H. Galjaard, and O.P. van Diggelen Elevated plasma chitotriosidase activity in various lysosomal storage disorders J Inherit Metab Dis 18 1995 717 722
23. L. Malaguarnera, M. Musumeci, M. Di Rosa, A. Scuto, and S. Musumeci Interferon-gamma, tumor necrosis factor-alpha, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages J Clin Lab Anal 19 2005 128 132
24. E.M. Fach, L.-A. Garulacan, J. Gao, Q. Xiao, S.M. Storm, Y.P. Dubaquie, S.A. Hefta, and G.J. Opiteck In vitro biomarker discovery for atherosclerosis by proteomics Mol Cell Proteomics 3 2004 1200 1210
25. I. Tabas Macrophage death and defective inflammation resolution in atherosclerosis Nat Rev Immunol 10 2010 36 46
26. A. Mantovani, C. Garlanda, and M. Locati Macrophage diversity and polarization in atherosclerosis: a question of balance Arterioscler Thromb Vasc Biol 29 2009 1419 1423
27. E. Laurat, B. Poirier, E. Tupin, G. Caligiuri, G.K. Hansson, J. Bariety, and A. Nicoletti In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice Circulation 104 2001 197 202
28. F.O. Martinez, L. Helming, and S. Gordon Alternative activation of macrophages: an immunologic functional perspective Annu Rev Immunol 27 2009 451 483
29. X. Han, S. Kitamoto, H. Wang, and W.A. Boisvert Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice FASEB J 24 2010 2869 2880
30. L.A. Boven, M. van Meurs, R.G. Boot, A. Mehta, L. Boon, J.M. Aerts, and J.D. Laman Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages Am J Clin Pathol 122 2004 359 369
31. M. Van Eck, M.P. De Winther, N. Herijgers, L.M. Havekes, M.H. Hofker, P.H. Groot, and T.J. Van Berkel Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in ApoE-deficient mice Arterioscler Thromb Vasc Biol 20 2000 2600 2606
32. N. Herijgers, M.P. de Winther, M. Van Eck, L.M. Havekes, M.H. Hofker, P.M. Hoogerbrugge, and T.J. Van Berkel Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice J Lipid Res 41 2000 1402 1409
33. M.P. de Winther, M.J. Gijbels, K.W. van Dijk, P.J. van Gorp, H. suzuki, T. Kodama, R.R. Frants, L.M. Havekes, and M.H. Hofker Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice Atherosclerosis 144 1999 315 321
34. K.J. Moore, V.V. Kunjathoor, S.L. Koehn, J.J. Manning, A.A. Tseng, J.M. Silver, M. McKee, and M.W. Freeman Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice J Clin Invest 115 2005 2192 2201
35. M.A. Kennedy, G.C. Barrera, K. Nakamura, A. Baldan, P. Tarr, M.C. Fishbein, J. Frank, O.L. Francone, and P.A. Edwards ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation Cell Metab 1 2005 121 131
36. B.L. Vaisman, G. Lambert, M. Amar, C. Joyce, T. Ito, R.D. Shamburek, W.J. Cain, J. Fruchart-Najib, E.D. Neufeld, A.T. Remaley, H.B. Brewer Jr., and S. Santamarina-Fojo ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice J Clin Invest 108 2001 303 309
37. S. Rust, M. Rosier, H. Funke, J. Real, Z. Amoura, J.C. Piette, J.F. Deleuze, H.B. Brewer, N. Duverger, P. Denefle, and G. Assmann Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 Nat Genet 22 1999 352 355
38. C. Serfaty-Lacrosniere, F. Civeira, A. Lanzberg, P. Isaia, J. Berg, E.D. Janus, M.P. Smith Jr., P.H. Pritchard, J. Frohlich, R.S. Lees, G.F. Barnard, J.M. Ordovas, and E.J. Schaefer Homozygous Tangier disease and cardiovascular disease Atherosclerosis 107 1994 85 98
39. M. van Eck, I.S. Bos, W.E. Kaminski, E. Orso, G. Rothe, J. Twisk, A. Bottcher, E.S. Van Amersfoort, T.A. Christiansen-Weber, W.P. Fung-Leung, T.J. Van Berkel, and G. Schmitz Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues Proc Natl Acad Sci USA 99 2002 6298 6303
40. R.J. Aiello, D. Brees, P.A. Bourassa, L. Royer, S. Lindsey, T. Coskran, M. Haghpassand, and O.L. Francone Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages Arterioscler Thromb Vasc Biol 22 2002 630 637
41. G. Chinetti, J.C. Fruchart, and B. Staels Peroxisome proliferator- activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation Inflamm Res 49 2000 497 505
42. P. Tontonoz, L. Nagy, J.G. Alvarez, V.A. Thomazy, and R.M. Evans PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL Cell 93 1998 241 252
43. A. Coste, M. Dubourdeau, M.D. Linas, S. Cassaing, J.C. Lepert, P. Balard, S. Chalmeton, J. Bernad, C. Orfila, J.P. Seguela, and B. Pipy PPARgamma promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13 Immunity 19 2003 329 339
44. M.A. Bouhlel, B. Derudas, E. Rigamonti, R. Dievart, J. Brozek, S. Haulon, C. Zawadzki, B. Jude, G. Torpier, N. Marx, B. Staels, and G. Chinetti-Gbaguidi PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties Cell Metab 6 2007 137 143
45. A. Chawla, W.A. Boisvert, C.H. Lee, B.A. Laffitte, Y. Barak, S.B. Joseph, D. Liao, L. Nagy, P.A. Edwards, L.K. Curtiss, R.M. Evans, and P. Tontonoz A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis Mol Cell 7 2001 161 171
46. A.C. Li, C.J. Binder, A. Gutierrez, K.K. Brown, C.R. Plotkin, J.W. Pattison, A.F. Valledor, R.A. Davis, T.M. Willson, J.L. Witztum, W. Palinski, and C.K. Glass Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma J Clin Invest 114 2004 1564 1576
47. I. Piras, A. Falchi, A. Melis, M.E. Ghiani, C.M. Calo, L. Varesi, and G. Vona 24 bp duplication of CHIT1 gene is not correlated with coronary artery disease in Corsica Island (France) Exp Mol Pathol 83 2007 490 492
48. F. Fusetti, H. von Moeller, D. Houston, H.J. Rozeboom, B.W. Dijkstra, R.G. Boot, J.M.F.G. Aerts, and D.M.F. van Aalten Structure of human chitotriosidase. Implications for specific inhibitor design and function of mammalian chitinase-like lectins J Biol Chem 277 2002 25537 25544